Compare AU

Compare CURE vs. HACK

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the BetaShares Global Cybersecurity ETF (HACK). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

HACK

Popularity

Low

Medium

Pearlers invested

82

1,354

Median incremental investment

$619.50

$749.56

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$2,036.16

Average age group

> 35

26 - 35


Key Summary

CURE

HACK

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

HACK seeks to track the performance of the NASDAQ CTA Cybersecurity Index prior to expenses and fees.

Top 3 holdings

Natera Inc (3.41 %)

Incyte Corp (2.94 %)

Gilead Sciences Inc (2.88 %)

BROADCOM INC (9.09 %)

INFOSYS LTD (8.80 %)

CROWDSTRIKE HOLDINGS INC (8.39 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Information Technology (73.62 %)

Other (17.32 %)

Industrials (9.06 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

United States (79.37 %)

India (7.63 %)

Israel (3.99 %)

Management fee

0.45 %

0.67 %


Key Summary

CURE

HACK

Issuer

Global X

BetaShares

Tracking index

S&P Biotechnology Select Industry

Nasdaq CTA Cybersecurity Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0.67 %

Price

$49.94

$14.14

Size

$38.065 million

$1.149 billion

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.24 %

4.95 %

Market

ASX

ASX

First listed date

12/11/2018

01/09/2016

Purchase fee

$6.50

$6.50


Community Stats

CURE

HACK

Popularity

Low

Medium

Pearlers invested

82

1,354

Median incremental investment

$619.50

$749.56

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$2,036.16

Average age group

> 35

26 - 35


Pros and Cons

CURE

HACK

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

  • Higher management fee

CURE

HACK

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home